Direct supply from state-of-the-art manufacturing infrastructure with certified analytical COAs, HPLC purity profiling, and global cold-chain fulfillment.
RU-58841 (also known as PSK-3841 or HMR-3841) is a specific non-steroidal anti-androgen (NSAA) compound originally synthesized by French pharmaceutical researchers in the late 1990s. Unlike systemic androgen receptor antagonists such as Finasteride or Dutasteride, which operate via 5α-reductase enzymatic inhibition, RU-58841 exhibits high affinity for androgen receptors locally within target hair follicle tissue.
From an industrial chemistry perspective, RU-58841 competes directly with dihydrotestosterone (DHT) at the receptor site, effectively suppressing DHT-induced signal transduction without altering systemic serum hormone concentrations or gonadotropin dynamics. This localized receptor selectivity makes RU-58841 a highly targeted raw material for active dermatological research, cosmetic formulation development, and clinical hair biology studies worldwide.
Chinese chemical manufacturers have pioneered scalable, ultra-pure synthetic routes for RU-58841, standardizing mass production at cGMP-compliant chemical production facilities to fulfill increasing global demand from pharmaceutical laboratories, personal care formulation specialists, and research institutions.
Standardized chemical reference metrics maintained across our domestic manufacturing plants:
Analyzing global supply chain shifts, procurement requirements, and why top-tier biopharmaceutical firms source raw active ingredients from China.
The global androgenetic alopecia therapy market is projected to surpass USD 15 Billion by 2030. As research entities seek novel non-hormonal topicals, high-purity RU-58841 raw powder has emerged as a cornerstone compound for specialized formulation testing and pre-clinical evaluations.
China accounts for over 70% of the world's active pharmaceutical ingredient (API) intermediate output. Chinese factories possess advanced chemical reactors, robust raw material supply chains, and highly trained organic synthesis teams, providing unparalleled cost efficiencies and industrial scalability.
International enterprise buyers demand rigorous documentation. Qualified Chinese suppliers provide full analytical transparency, including High-Performance Liquid Chromatography (HPLC), Proton Nuclear Magnetic Resonance (1H-NMR), Mass Spectrometry (MS), and Heavy Metal Analysis.
Behind China's top-tier production facilities: Multi-step organic synthesis, continuous crystallization, and ultra-high resolution purification.
The standard commercial synthesis of RU-58841 in Chinese factories starts from 4-nitro-3-(trifluoromethyl)aniline or related substituted aromatic precursors. The process involves high-yield multi-step chemical reactions:
| Test Parameter | Internal Standard Requirement | Typical Test Result |
|---|---|---|
| Chemical Purity (HPLC) | ≥ 99.0% | 99.45% |
| Single Impurity | ≤ 0.5% | 0.12% |
| Loss on Drying (LOD) | ≤ 1.0% | 0.34% |
| Residue on Ignition | ≤ 0.1% | 0.04% |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm Total | Conforms (< 2 ppm) |
| Residual Solvents (Ethanol/DCM) | Conforms to ICH Guidelines | Passed |
RU-58841 powder is light-sensitive and subject to slow thermal degradation if exposed to moisture and elevated temperatures. Premium Chinese factories implement enterprise-grade packaging standards:
Navigating global chemical export laws requires absolute compliance and flawless documentation. Leading Chinese suppliers provide complete trade documentation bundles for seamless global clearance:
Every commercial bulk order of RU-58841 includes a comprehensive Certificate of Analysis (COA) matching the specific lot number, Material Safety Data Sheets (MSDS / SDS) adhering to GHS standards, and raw spectral analytical data (HPLC chromatogram and 1H-NMR spectrum scans).
With established fulfillment channels across North America, the European Union, the United Kingdom, Australia, South Africa, and Latin America, tier-1 suppliers guarantee safe, compliant, and expedient door-to-door delivery.
Connecting the global scientific and industrial community with high-value APIs, custom synthesis, and enterprise contract manufacturing.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard allows us to offer flexible, scalable and cost-effective solutions for clients globally.
View Details
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Specialized R&D synthesis teams providing high-yield chemical customization, multi-step peptide synthesis, and analytical method development.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex maintains robust strategic partnerships across global pharmaceutical networks, analytical laboratories, and international procurement platforms.
In-depth technical papers, synthesis breakthroughs, and product profiles from our scientific team.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous peptide tuftsin, modified to offer superior metabolic stability and high regulatory activity across central nervous pathways.
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and life science institutes. Tβ4 plays a critical role in cellular migration, actin-sequestering mechanisms, and tissue regeneration research.
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis acceleration, and inflammatory pathway regulation. Produced via solid-phase peptide synthesis (SPPS).
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH (4-10) fragment, features elevated enzymatic resistance and high binding specificity.
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to selectively bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure, it supports cellular bioenergetics and mitigates oxidative stress.
View DetailsEssential guidance for commercial buyers, laboratory managers, and enterprise procurement specialists importing RU-58841 from China.
Explore our extended catalog of certified therapeutic raw materials, custom synthetic intermediate compounds, and anti-aging biological actives.
